semaglutide and kidney problems FLOW clinical Trial (funded by Novo Nordisk): showed 24% reduction in the risk of disease-related events in people with type 2 diabetes chronic kidney disease compared to placebo. Investigators Chronic Kidney Disease | Ozempic®

Taken together, these data highlight the role of GPx1 in preventing cardiac injury in response to physiological stressors

You want to lose fat while retaining muscle

It is typically taken once a week for the sole purpose of weight loss

In contrast, Zepbound has already demonstrated strong efficacy and safety across multiple Phase III programs, driving its rapid uptake in both diabetes and obesity

Semaglutide is a medication used to treat type 2 diabetes and aid in weight loss

GLP-1 Medical Weight Loss At SVIA Medspa in Los Gatos and San Mateo, we offer a patient-focused GLP-1 medical weight loss program designed for lasting results